2015PAD指南与阿片类镇痛药在ICU中的合理使用-liudong-酒泉重点.pptVIP

Intensive Care Med (2011) 37:469–476 A total of 11 randomised controlled trials, comparing remifentanil with another opioid or hypnotic agent in 1067 critically ill adult patients, were identified from the Cochrane controlled trials register and EMBASE and MEDLINE databases, and subjected to meta-analysis. Remifentanil was associated with a reduction in the time to tracheal extubation after cessation of sedation (weighted-mean-difference )2.04 h (95% CI )0.39 to )3.69 h); p = 0.02). Remifentanil was, however, not associated with a significant reduction in mortality (relative risk 1.01 (95% CI